We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.2%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$43.6B
AUM Growth
+$2.01B
(+4.8%)
Cap. Flow
+$1.75B
Cap. Flow
% of AUM
4%
Top 10 Holdings %
Top 10 Hldgs %
18.28%
Holding
1,493
New
278
Increased
387
Reduced
400
Closed
399
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$674M |
| 2 |
IBM
IBM
|
+$408M |
| 3 |
Toronto Dominion Bank
TD
|
+$392M |
| 4 |
Biogen
BIIB
|
+$340M |
| 5 |
Boeing
BA
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$366M |
| 2 |
CVS Health
CVS
|
+$350M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$333M |
| 4 |
TSMC
TSM
|
+$323M |
| 5 |
Merck
MRK
|
+$283M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.47% |
| 2 | Healthcare | 17.17% |
| 3 | Financials | 16.49% |
| 4 | Consumer Discretionary | 12.16% |
| 5 | Industrials | 11.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Lincoln National
LNC
$8.72B
| $789K | ﹤0.01% |
10,800
-99,155
| -90% | -$7.78M |
|
902
Intrepid Potash
IPI
$504M
| $787K | ﹤0.01% |
21,611
-17,031
| -44% | -$659K |
|
|
EGC
903
DELISTED
Energy XXI Gulf Coast, Inc. Common Stock
EGC
| $780K | ﹤0.01% |
203,061
-298,406
| -60% | -$1.73M |
|
904
AvalonBay Communities
AVB
$26.3B
| $773K | ﹤0.01% |
+4,700
| New | +$770K |
|
905
PennyMac Financial
PFSI
$3.94B
| $766K | ﹤0.01% |
+33,813
| New | +$788K |
|
|
MNK
906
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $760K | ﹤0.01% |
52,458
-1,302,286
| -96% | -$23.5M |
|
907
Hallador Energy
HNRG
$756M
| $752K | ﹤0.01% |
109,529
-27,475
| -20% | -$183K |
|
|
BT
908
DELISTED
BT Group plc (ADR)
BT
| $750K | ﹤0.01% |
46,400
-654,702
| -93% | -$11.2M |
|
|
ADAP
909
DELISTED
Adaptimmune Therapeutics
ADAP
| $748K | ﹤0.01% |
66,565
+29,977
| +82% | +$262K |
|
|
MTL
910
DELISTED
Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs)
MTL
| $747K | ﹤0.01% |
171,645
-243,232
| -59% | -$1.2M |
|
|
CSS
911
DELISTED
CSS Industries, Inc.
CSS
| $741K | ﹤0.01% |
42,342
+7,573
| +22% | +$169K |
|
912
CytomX Therapeutics
CTMX
$745M
| $735K | ﹤0.01% |
+25,823
| New | +$737K |
|
|
HSTO
913
DELISTED
Histogen Inc. Common Stock
HSTO
| $728K | ﹤0.01% |
620
-89
| -13% | -$98.4K |
|
|
MCF
914
DELISTED
Contango Oil & Gas Co.
MCF
| $721K | ﹤0.01% |
203,188
-21,187
| -9% | -$85.8K |
|
|
FCRD
915
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
| $713K | ﹤0.01% |
91,726
-142,928
| -61% | -$1.22M |
|
916
TotalEnergies
TTE
$195B
| $704K | ﹤0.01% |
1,117,825
-14,815,946
| -93% | -$9.26M |
|
917
Brink's
BCO
$4.55B
| $699K | ﹤0.01% |
9,800
-39,047
| -80% | -$3M |
|
|
LADR
918
Ladder Capital
LADR
$1.22B
| $685K | ﹤0.01% |
+45,400
| New | +$664K |
|
919
Riverview Bancorp
RVSB
$107M
| $684K | ﹤0.01% |
73,252
-7,600
| -9% | -$69.2K |
|
920
Medpace
MEDP
$16.8B
| $681K | ﹤0.01% |
19,514
+5,733
| +42% | +$209K |
|
921
NCR Voyix
VYX
$1.12B
| $680K | ﹤0.01% |
+35,164
| New | +$741K |
|
922
Cheesecake Factory
CAKE
$5.52B
| $677K | ﹤0.01% |
+14,039
| New | +$674K |
|
|
CCT
923
DELISTED
Corporate Capital Trust, Inc.
CCT
| $677K | ﹤0.01% |
+40,083
| New | +$640K |
|
924
PTC Therapeutics
PTCT
$6.19B
| $674K | ﹤0.01% |
+24,922
| New | +$631K |
|
925
Franklin Covey
FC
$242M
| $669K | ﹤0.01% |
24,870
-33,321
| -57% | -$908K |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2018 Portfolio in Review
As of Q1 2018, Arrowstreet Capital held 1,493 positions worth $43.6B, up 4.8% from $41.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital deployed $1.75B of net new capital in Q1 2018, opening 278 new positions and adding to 387 existing holdings. Its largest new stake was AB InBev: 2,063,707 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Philip Morris, an estimated $366M trimmed.
- Arrowstreet Capital's largest Q1 2018 buy was AB InBev: 2,063,707 shares worth $227M.
- Arrowstreet Capital added most to AbbVie in Q1 2018, an estimated $674M increase.
- Arrowstreet Capital's biggest Q1 2018 reduction was Philip Morris, cutting an estimated $366M.
- Arrowstreet Capital fully exited iShares MSCI South Korea ETF in Q1 2018, selling an estimated $271M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $43.6B portfolio in Q1 2018.
- Arrowstreet Capital opened 278 new positions and closed 399 in Q1 2018.
- Arrowstreet Capital's portfolio value rose 4.8% quarter-over-quarter to $43.6B.
Based on Arrowstreet Capital's 13F filing for Q1 2018, filed 14 May 2018.